110 related articles for article (PubMed ID: 16438868)
1. [Multivariate analysis of prognosis in gastrointestinal stromal tumor].
Bai YK; Shao YF; Shi SS; Gao YN; Sun YT; Cheng SJ; Liu XY
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):598-601. PubMed ID: 16438868
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of prognostic and clinicopathologic factors in gastrointestinal stromal tumors of the stomach].
Bai YK; Shao YF; Cao WL; Shi SS; Yu LW
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):21-5. PubMed ID: 17253167
[TBL] [Abstract][Full Text] [Related]
3. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of prognostic factors in gastrointestinal stromal tumors of the small intestine].
Bai YK; Shao YF; Shi SS; Gao YN; Sun YT; Wan YL
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):213-6. PubMed ID: 16167230
[TBL] [Abstract][Full Text] [Related]
5. Colorectal mesenchymal tumors - from smooth muscle tumors to stromal tumors.
Tai WC; Chuah SK; Lin JW; Chen HH; Huang HY; Kuo CM; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Nov; 20(5):1157-64. PubMed ID: 18949416
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of prognostic factors for patients with gastrointestinal stromal tumors].
Jie ZG; Xie XP; Qin KW; Liu Y; Li ZR; Dai AB; Yao YX
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):210-2. PubMed ID: 16167229
[TBL] [Abstract][Full Text] [Related]
8. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of clinicopathology and prognosis in 181 patients with gastrointestinal stromal tumors].
Zhang Y; Cao H; Wang M; Shen DP; Shen ZY; Ni XZ; Wu ZY; Shen YY; Liu Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):150-4. PubMed ID: 19296250
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors in gastrointestinal stromal tumors among a group of Mexican patients].
Medina-Franco H; Aguilar-Jiménez JR; Medina-Cuairán JZ
Gac Med Mex; 2009; 145(2):91-6. PubMed ID: 19518014
[TBL] [Abstract][Full Text] [Related]
12. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
13. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
[TBL] [Abstract][Full Text] [Related]
14. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.
Rutkowski P; Nowecki ZI; Michej W; Debiec-Rychter M; Woźniak A; Limon J; Siedlecki J; Grzesiakowska U; Kakol M; Osuch C; Polkowski M; Głuszek S; Zurawski Z; Ruka W
Ann Surg Oncol; 2007 Jul; 14(7):2018-27. PubMed ID: 17473953
[TBL] [Abstract][Full Text] [Related]
15. Prognostic assessment of gastrointestinal stromal tumor.
Yan H; Marchettini P; Acherman YI; Gething SA; Brun E; Sugarbaker PH
Am J Clin Oncol; 2003 Jun; 26(3):221-8. PubMed ID: 12796588
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization.
Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V
J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946
[TBL] [Abstract][Full Text] [Related]
17. Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studies.
Tsai MC; Lin JW; Lin SE; Chen HH; Lee CM; Hu TH
Dis Colon Rectum; 2008 Oct; 51(10):1535-43. PubMed ID: 18633679
[TBL] [Abstract][Full Text] [Related]
18. The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST.
Shirin H; Kravtsov V; Shahmurov M; Shabat VS; Krinshpon I; Alin A; Avinoach I; Avni Y
Digestion; 2007; 75(1):4-9. PubMed ID: 17406118
[TBL] [Abstract][Full Text] [Related]
19. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
